{{ subpage.title }}

GZERO event highlights: IMF chief, G7 vaccine pledges, global health security

For IMF Managing Director Kristalina Georgieva (above), a two-track pandemic means a two-track recovery that'll hurt the entire world in the long run. That's why she anticipates G7 leaders meeting this week will commit to sending about one billion doses of COVID vaccines to the developing world by the end of the year in new financing and shots unused by wealthy nations. Georgieva hopes it'll be a summit that gives all countries "a fair short in the arm, a fair shot at the future."

Georgieva was one of many experts who joined this week's two-part livestream discussion about post-pandemic health security hosted by GZERO Media in partnership with Flagship Pioneering, Beyond the Pandemic: A Radical New Approach to Health Security, presented in partnership with Flagship Pioneering.

Read Now Show less

How will we deal with the next pandemic?

While most of the world is still grappling with COVID, some countries — mostly wealthy ones with early access to vaccines — are thinking about preparing for the next pandemic. This sentiment ties into a wider debate about health security that was missing when the virus hit us all early last year.

Indeed, we should aspire to ensure the health security of our population instead of waiting for it to get sick, Flagship Pioneering CEO Noubar Afeyan said on June 9, during a live discussion, Stronger Partnerships for a Healthier World: Mutually Assured Protection — the second in GZERO Media's two-part discussion, Beyond the Pandemic: A Radical New Approach to Health Security, presented in partnership with Flagship Pioneering.

Read Now Show less

Let's learn from COVID to prevent the next pandemic

Days before G7 leaders meet in the UK to talk about how to "build back better" after the pandemic, experts are warning them that they should not lose sight of the opportunity to learn from the experience of COVID to be more prepared when the next public crisis hits. Below are a few insights from a livestream discussion between political leaders, policy makers, health experts and scientists, entitled Beyond the Pandemic: A Radical New Approach to Health Security, hosted by GZERO Media in partnership with Flagship Pioneering.

Read Now Show less

Watch our live event: global health beyond the pandemic

Could the biggest health crisis of our lifetimes actually lead to a healthier world? Watch the second part of our live event series about what public health will look like after the COVID-19 pandemic, presented in partnership with Flagship Pioneering, the bio-platform company that founded Moderna and dozens of other life sciences firms.

Days before world leaders G7 meeting, we will bring political leaders and policy makers together with health experts and scientists to discuss lessons learned from and the latest innovations to preempt both COVID-19 variants and future infectious disease pandemics.

Attendance is free and open to the public. Please register to attend.

The virtual event will be hosted by Noubar Afeyan, founder & CEO of Flagship Pioneering, and Ian Bremmer, president and founder of Eurasia Group and GZERO Media.

Read Now Show less

The race to vaccinate: Dr. Atul Gawande provides perspective

Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins Ian Bremmer on GZERO World to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson & Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.

Podcast: The Race to Vaccinate: Dr. Atul Gawande Provides Perspective

Listen: Can the United States vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins the podcast to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson & Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.

Subscribe to the GZERO World Podcast on Apple Podcasts, Spotify, Stitcher, or your preferred podcast platform to receive new episodes as soon as they're published.

Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?

Without the help of the US government initiative "Operation Warp Speed," Moderna co-founder Noubar Afeyan says that it would have been impossible for the company to develop and deliver its vaccine so quickly. The fact, he says, that the American people may be days away from receiving its first doses is, in large part, thanks to their taxpayer dollars. Does President Trump, himself, deserve credit? "Without caveat," Afeyan says. He spoke with Ian Bremmer on GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

How development of the COVID-19 vaccine shattered records

They said it couldn't be done: a vaccine developed in record time. In 1967, Merck had a license for a mumps vaccine, less than five years for work that normally takes decades. But that record is now being shattered as the COVID-19 vaccine reaches the market in less than a year. It's an unprecedented scientific development in a whirlwind year of crisis.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

Subscribe to GZERO Media's newsletter, Signal

Latest